Annual Results Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 6.96% vs 6.47% in Mar 2025
Standalone Net Profit
YoY Growth in year ended Mar 2026 is -19.57% vs 29.95% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -24.81% vs -6.70% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -11.75% vs 20.29% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of TTK Healthcare With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
857.28
2,699.27
-1,841.99
-68.24%
Other Operating Income
0.00
0.00
0.00
Total Operating income
857.28
2,699.27
-1,841.99
-68.24%
Raw Material Cost
200.49
1,737.11
-1,536.62
-88.46%
Purchase of Finished goods
203.05
24.71
178.34
721.73%
(Increase) / Decrease In Stocks
-0.06
3.21
-3.27
-101.87%
Employee Cost
165.16
266.37
-101.21
-38.00%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
262.45
332.47
-70.02
-21.06%
Total Expenditure (Excl Depreciation)
831.10
2,363.88
-1,532.78
-64.84%
Operating Profit (PBDIT) excl Other Income
26.18
335.39
-309.21
-92.19%
Other Income
72.15
85.32
-13.17
-15.44%
Operating Profit (PBDIT)
98.33
420.71
-322.38
-76.63%
Interest
2.93
25.63
-22.70
-88.57%
Exceptional Items
-4.07
0.00
-4.07
Gross Profit (PBDT)
91.33
395.08
-303.75
-76.88%
Depreciation
8.76
64.22
-55.46
-86.36%
Profit Before Tax
82.56
330.87
-248.31
-75.05%
Tax
16.88
85.19
-68.31
-80.19%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
65.68
245.68
-180.00
-73.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
65.68
245.68
-180.00
-73.27%
Equity Capital
14.13
171.00
-156.87
-91.74%
Face Value
10.00
10.00
0.00
Reserves
1,096.31
1,384.48
-288.17
-20.81%
Earnings per share (EPS)
46.48
14.37
32.11
223.45%
Diluted Earnings per share
46.48
14.37
32.11
223.45%
Operating Profit Margin (Excl OI)
3.05%
12.43%
0.00
-9.38%
Gross Profit Margin
10.65%
14.64%
0.00
-3.99%
PAT Margin
7.66%
9.10%
0.00
-1.44%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 857.28 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.96% vs 6.47% in Mar 2025
Annual - Standalone Net Profit
Standalone Net Profit 65.68 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -19.57% vs 29.95% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.18 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -24.81% vs -6.70% in Mar 2025
Annual - Interest
Interest 2.93 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -11.75% vs 20.29% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.05%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
